Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the full study record with an error page. This blocks access to the trial's overview, eligibility criteria, locations, and outcomes.SummaryDifference17%

- Check34 days agoChange DetectedStatus on the study page updated to 'Results Submitted' from 'No Results Posted'. This indicates the trial's results have been submitted for review and will appear in the results section.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page's revision tag changed from v3.6.5 to v3.6.6. This indicates a minor update to the page's version metadata rather than any content changes.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page shows a new revision tag (v3.6.5) replacing the previous v3.6.4, indicating a minor platform update to the page that does not change study content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe site revision was updated from v3.6.3 to v3.6.4, signalling a maintenance/version update to the ClinicalTrials.gov page infrastructure. The update does not modify the study details, eligibility criteria, or other content presented on the page.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. This change does not modify study data, eligibility criteria, or results.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.